SYRINGE DRIVER MEDICATIONS

Similar documents
Syringe driver in Palliative Care

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

Renal Palliative Care Last Days of Life

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

Algorithms for Symptom Management. In End of Life Care

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Renal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

Isle of Wight Syringe Driver Compatibility Guidelines

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

Clatterbridge Centre for Oncology

End of life prescribing guidance

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

Supportive Care. End of Life Phase

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

Care in the Last Days of Life

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110

End Stage Liver Disease Regional Audit Casenote Survey

Using syringe pumps in palliative care

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1

Syringe Drivers. Back to top

Palliative care for heart failure patients. Susan Addie

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

Alternative Routes of Drug Administration (analgesia) Dr Andrew Dickman Consultant Pharmacist

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

Conservative Management of Uraemia

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

Care of dying adults in the last days of life. Improving care at the very end of life.

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

This survey aims to look at individual practice and can be completed by any healthcare professional.

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Symptom Management Guidelines for End of Life Care

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure

Palliative Prescribing - Pain

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

Lothian Palliative Care Guidelines POCKET EDITION 2004

Eastern Health and Social Services Board Palliative Care

What s New 2003? What new treatments? What have you discontinued? More information please!

Planning for the future; A guide to symptom control at end of life in advanced dementia

Coversheet for Network Site Specific Group Agreed Documentation

BACKGROUND Measuring renal function :

Palliative Care Formulary

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

Palliative Care Impact Survey

tablet/capsule Paracetamol 500mg

Palliative Care. Pocketbook 4

MND Just in Case kit Information for GPs

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist

McKinley T34 Syringe Pump Policy and Procedure

SCHEDULE 2 THE SERVICES

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

POLICY / PROCEDURE FOR THE USE OF THE McKinley T34 SYRINGE DRIVER

Guidelines for Syringe Driver Management in Palliative Care in New Zealand

East Kent Prescribing Group

DRUG COMBINATIONS IN PALLIATIVE CARE: A COMPATIBILITY STUDY

PRIMARY CARE PALLIATIVE CARE FORMULARY

Palliative Care. Guidelines for prescribing analgesic in palliative care THREE PRESCRIBING IN PALLIATIVE CARE GUIDELINES FOR MANAGING COMMON SYMPTOMS

Syringe drivers. *precipitation may be seen at higher doses

AMBER Prescribing should only be undertaken in General Practice under the advice of the local hospice or specialist palliative care team.

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon

Prescribing Examples: Basics

Symptom Management in the last weeks & days of life. Facilitator: Vernon Davis RN/Community Team Leader Rowcroft Community Team

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

Yorkshire Cancer Network

West Midlands Palliative Care Physicians. Palliative care. Guidelines for the use of drugs in symptom control

BJF Acute Pain Team Formulary Group

Palliative Patient in Emergency Department

ADULT SYRINGE DRIVER PROTOCOL (T34)

Administration and Supply of Emergency Medicines

CCR-BPD020 BERKSHIRE ADULT PALLIATIVE CARE GUIDELINES. SECTION 3: End of Life Symptom Control. Berkshire Healthcare NHS Foundation Trust

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

PRIMARY CARE PALLIATIVE CARE FORMULARY

Administration of Drugs via the CME Medical T34 Syringe Driver Standard Operating Procedure

GUIDELINES FOR CONVERSION FROM A STRONG OPIOID TO METHADONE

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

Implementing the recommendation on medication management and symptom control

ESSEX PALLIATIVE, SUPPORTIVE AND END OF LIFE CARE GROUP FORMULARY AND GUIDELINES FOR MANAGEMENT

General Palliative Care Guidelines for the Management of Pain at the End of Life in Adult Patients

Ketamine and Methadone Supra- Regional Audit Presentation

Syringe Pumps: Guidance for the use with babies, children and young people in the community setting within Worcestershire

If dialysis is not started, established renal failure will eventually lead to death although the time scale is variable from weeks to months.

The John Walls Renal Unit Leicester General Hospital University Hospitals of Leicester

PALLIATIVE CARE PRESCRIBING

What else is new (other symptoms) DR ANDREW DAVIES

Transcription:

SYRINGE DRIVER MEDICATIONS Christine Hull & Anita Webb Staff Nurses, Hospice in the Home 2015

Analgesics:- Groups of Medication used in Syringe Drivers Morphine sulphate Diamorphine Oxycodone Alfentanil

Anti-emetics Cyclizine Metoclopramide Haloperidol Levomepromazine

Sedation Midazolam Levomepromazine Haloperidol

Anti-secretory Hyoscine Butylbromide (Buscopan) Hyoscine Hydrobromide Glycopyrronium

Others Diclofenac Dexamethasone Ondansetron Octreotide

Diluents and Compatibility Drugs in syringe drivers are generally prepared with a diluent, commonly water for injection or Sodium Chloride 0.9% The diluent used should be compatible with the medicines to minimise site reactions and enable medicines to be given over a set period The appropriate diluent can contribute to symptom management and wellbeing of the patient

Watson et al (2011) Palliative Adult Network Guidelines 3rd Edition recommend water for injection as the diluent of choice with specific exceptions For example:- Sodium Chloride is the diluent of choice for Ketamine and Diclofenac

Drug Compatibility This is dependant on a number of factors which include:- Dose and strength of medicine Ph of each medicine and the final solution Diluting the mixture to the maximum volume may reduce both the risk of adverse site reactions and incompatibility The more drugs mixed together, the greater the risk of incompatibility

Troubleshooting If the solution in the syringe driver precipitates, crystallises or discolours, it may result from:- Solution being too warm Solution being over exposed to sunlight Too many medications added to the syringe Medications are not compatible Medication is past its expiry date Subcutaneous infusions should be monitored regularly to avoid the above Patient should be monitored regularly if symptom control is to be maintained

Transdermal patches If a patient is currently using a transdermal Buprenorphine or Fentanyl patch, treatment should continue when starting a syringe driver Breakthrough pain should be treated with equivalent breakthrough doses of s/c opioid For example, a Fentanyl patch of 25mcgs/hr requires a breakthrough of 5mgs of Diamorphine The total daily breakthrough medication is then given via the syringe driver in addition to the transdermal patch

Drug Conversions Oral Morphine to s/c Diamorphine divide 24hr dose by 3 For Example:- 180mg Oramorph in 24 hrs = 60mg s/c Diamorphine in 24 hrs Breakthrough dose is 1/6 th of 24hr dose, which is 10mg s/c Diamorphine

Drug Conversions cont. Oral Morphine to s/c Morphine divide 24 hr dose by 2 For example:- 60mg Oramorph = 30mg s/c Morphine Sulphate Breakthrough dose is 1/6 th of the 24hr dose, which is 5mg of s/c Morphine Sulphate

Drug Conversions cont. Oral Oxycodone to s/c Oxycodone divide the 24hr dose by 2 For example:- 20mg of oral Oxycodone = 10mg s/c Oxycodone

Drug Conversions cont. s/c Diamorphine to s/c Oxycodone For example:- 40mg of s/c Diamorphine = 120mg Oramorph 120mg of oral Oramorph = 60mg oral Oxycodone 60mg of oral Oxycodone = 30mg s/c Oxycodone

Converting m/r Morphine to Diamorphine For example:- Zomorph 30mg bd = Zomorph 60mg in 24 hrs Divide by 3 = 20mg s/c Diamorphine Breakthrough dose = 2.5 5mg s/c Diamorphine

Converting s/c Diamorphine to s/c Alfentanil Alfentanil is approximately 10 times as potent as Diamorphine For example:- 10mg s/c Diamorphine = 1mg s/c Alfentanil Breakthrough dose is 1/10 th of the 24hr dose which is 0.1mg s/c Alfentanil